Oscar Health (OSCR) Receivables (2020 - 2026)

Oscar Health's Receivables history runs 7 years deep, the most recent figure standing at $587.0 million for Q1 2026.

• Quarterly Receivables rose 20.1% year-over-year to $587.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $587.0 million (up 20.1% YoY) and the FY2025 annual result came in at $362.7 million, up 14.81% from the prior year.
• Receivables was $587.0 million for Q1 2026 at Oscar Health, up from $362.7 million in the prior quarter.
• Across five years, Receivables topped out at $587.0 million in Q1 2026 and bottomed at $33.7 million in Q4 2022.
• A 5-year average of $298.6 million and a median of $300.6 million in 2024 frame the typical range for Receivables.
• Annual changes were most pronounced in 2022 — Receivables slumped 75.65% — and 2023, when it soared 497.24%.
• Oscar Health's Receivables stood at $33.7 million in 2022, then surged by 497.24% to $201.3 million in 2023, then surged by 56.95% to $315.9 million in 2024, then advanced by 14.81% to $362.7 million in 2025, then surged by 61.86% to $587.0 million in 2026.
• Business Quant data shows OSCR's Receivables at $587.0 million in Q1 2026, $362.7 million in Q4 2025, and $445.5 million in Q3 2025.